Showing results (271-280 of 408) with videos related to
Sort By:
Pageof 41
Cancer Genetics and Cytogenetics|August 26, 2003
Absence of somatic ATM missense mutations in 58 mammary carcinomasJinong Feng, Jin Yan, Jiesheng Chen, et al.Genomics|September 1, 1991
Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptorG Sarkar, S Kapelner, D K Grandy, et al.Genome Biology and Evolution|November 18, 2010
ERAD components in organisms with complex red plastids suggest recruitment of a preexisting protein transport pathway for the periplastid membraneGregor Felsner, Maik S Sommer, Nicole Gruenheit, et al.Plos One|October 1, 2009
Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancerZhenbin Chen, Jinong Feng, Carolyn H Buzin, et al.Plant Molecular Biology|August 30, 2011
The localization of Tic20 proteins in Arabidopsis thaliana is not restricted to the inner envelope membrane of chloroplastsAnu B Machettira, Lucia E Gross, Maik S Sommer, et al.American Journal of Obstetrics and Gynecology|May 1, 1991
Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: a study of women in the Faroe Islands and DenmarkS F Olsen, H S Hansen, S Sommer, et al.Molecular Biology and Evolution|September 15, 2006
Nucleus-to-nucleus gene transfer and protein retargeting into a remnant cytoplasm of cryptophytes and diatomsSven B Gould, Maik S Sommer, Peter G Kroth, et al.Human Molecular Genetics|July 18, 2008
Somatic microindels in human cancer: the insertions are highly error-prone and derive from nearby but not adjacent sense and antisense templatesWilliam A Scaringe, Kai Li, Dongqing Gu, et al.Journal of Medical Genetics|June 27, 2009
High frequency of de novo mutations in Li-Fraumeni syndromeK D Gonzalez, C H Buzin, K A Noltner, et al.International Journal of Cancer|March 17, 2000
A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcomeH Blaszyk, A Hartmann, J M Cunningham, et al.Pageof 41